From: Efficacy and usability of a novel nebulizer targeting both upper and lower airways
pre | post | p-valuea | |||
---|---|---|---|---|---|
mean | SD | mean | SD | ||
Rhinitic patients | |||||
Total nasal inspiratory airflow (ml/s) | 275 | 216 | 359 | 188 | 0.030 |
Asthmatic patients | |||||
FEV 1 (l) | 1.59 | 0.63 | 1.90 | 0.80 | <0.001 |
Tiffeneau index (%) | 78 | 11.0 | 87 | 10.1 | <0.001 |
MMEF 25-75 (l/s) | 1.32 | 0.50 | 2.01 | 0.85 | <0.001 |